Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement
暂无分享,去创建一个
B. Meng | Xiaomeng Wang | S. Cao | Wen-chao Ma | Weijiao Du | Jie Cao
[1] S. Fabara,et al. Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review , 2022, Cureus.
[2] A. Goodman,et al. Erdheim-Chester disease: Consensus recommendations for the evaluation, diagnosis, and treatment in the molecular era. , 2020, Blood.
[3] Z. Amoura,et al. Erdheim-Chester disease. , 2020, Blood.
[4] Ryanne A. Brown,et al. Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib , 2018, American journal of ophthalmology case reports.
[5] S. Ascani,et al. Erdheim–Chester disease: description of two illustrative cases involving the lung , 2018, Histopathology.
[6] E. Jaffe,et al. The clinical spectrum of Erdheim-Chester disease: an observational cohort study. , 2017, Blood advances.
[7] K. Richani,et al. Erdheim-Chester disease with orbital involvement: Case report and ophthalmic literature review , 2016, Orbit.
[8] A. Fischer,et al. Revised Classification of Histiocytoses and Neoplasms of the Macrophage-dendritic Cell Lineages Histiocyte and Dendritic Cell Lineages the " L " (langerhans) Group , 2022 .
[9] V. Meignin,et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. , 2014, Blood.
[10] O. Abdel-Wahab,et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. , 2014, Blood.
[11] D. Dormont,et al. Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. , 2010, Radiology.
[12] J. Piette,et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature , 2006, Journal of Neurology.
[13] Dr. William Chester. Über Lipoidgranulomatose , 2005, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.